Contact
![Contact Meredith Alda](https://cdn.statcdn.com/contactPerson/3646.jpg)
Mon - Fri, 9am - 6pm (EST)
![Contact Yolanda Mega](https://cdn.statcdn.com/contactPerson/3195.jpg)
Mon - Fri, 9am - 5pm (SGT)
![Contact Kisara Mizuno](https://cdn.statcdn.com/contactPerson/2661.jpg)
Mon - Fri, 10:00am - 6:00pm (JST)
![Contact Lodovica Biagi](https://cdn.statcdn.com/contactPerson/863.jpg)
Mon - Fri, 9:30am - 5pm (GMT)
![Contact Carolina Dulin](https://cdn.statcdn.com/contactPerson/3012.jpg)
Mon - Fri, 9am - 6pm (EST)
Key regions: United Kingdom, China, Netherlands, Europe, Italy
The Other Medical Devices market in EU-27 is experiencing steady growth due to increasing customer preferences for innovative and advanced medical devices.
Customer preferences: Customers in the EU-27 are increasingly seeking medical devices that offer improved accuracy, reliability, and ease of use. They are willing to invest in technologically advanced devices that can provide more precise and efficient medical treatments. Additionally, there is a growing demand for portable and wearable medical devices that allow individuals to monitor their health conditions in real-time and take proactive measures to maintain their well-being.
Trends in the market: One of the key trends in the Other Medical Devices market in EU-27 is the adoption of digital health technologies. The integration of digital technologies, such as artificial intelligence, Internet of Things, and big data analytics, is revolutionizing the healthcare industry. Medical devices that can connect to smartphones or other devices, enabling remote monitoring and data analysis, are gaining popularity. This trend is driven by the need for improved patient outcomes, cost-effectiveness, and convenience. Another trend in the market is the increasing focus on personalized medicine. With advancements in genetic testing and molecular diagnostics, healthcare providers are able to tailor medical treatments to individual patients. This has created a demand for specialized medical devices that can deliver personalized therapies and diagnostics. The growing aging population in the EU-27 is also driving the demand for medical devices that can address age-related health issues, such as chronic diseases and mobility limitations.
Local special circumstances: The EU-27 market for Other Medical Devices is influenced by the regulatory environment and reimbursement policies in each country. The European Union has stringent regulations in place to ensure the safety and efficacy of medical devices. Companies operating in the market need to comply with the Medical Device Regulation (MDR) and obtain CE marking for their products. Additionally, reimbursement policies vary across EU-27 countries, which can impact the adoption of certain medical devices.
Underlying macroeconomic factors: The growth of the Other Medical Devices market in EU-27 is also influenced by macroeconomic factors such as healthcare expenditure, GDP growth, and population demographics. Increasing healthcare expenditure by governments and private healthcare providers is driving the demand for medical devices. GDP growth and rising disposable incomes in the EU-27 countries are enabling individuals to afford advanced medical devices. Furthermore, the aging population in the region is creating a larger customer base for medical devices, as older adults are more likely to require medical treatments and devices for age-related health conditions. In conclusion, the Other Medical Devices market in EU-27 is witnessing growth due to customer preferences for innovative and advanced medical devices. The adoption of digital health technologies and personalized medicine are key trends driving the market. The regulatory environment, reimbursement policies, healthcare expenditure, GDP growth, and population demographics are important factors shaping the market in EU-27.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)